Cited by 236Computational Drug Discovery MethodsMachine Learning in Materials ScienceNeural Networks and Applications

A renaissance of neural networks in drug discovery

Baskin, Igor I., Winkler, David, Tetko, Igor V.·2016·Expert Opinion on Drug Discovery

Abstract

INTRODUCTION: Neural networks are becoming a very popular method for solving machine learning and artificial intelligence problems. The variety of neural network types and their application to drug discovery requires expert knowledge to choose the most appropriate approach. AREAS COVERED: In this review, the authors discuss traditional and newly emerging neural network approaches to drug discovery. Their focus is on backpropagation neural networks and their variants, self-organizing maps and associated methods, and a relatively new technique, deep learning. The most important technical issues are discussed including overfitting and its prevention through regularization, ensemble and multitask modeling, model interpretation, and estimation of applicability domain. Different aspects of using neural networks in drug discovery are considered: building structure-activity models with respect to various targets; predicting drug selectivity, toxicity profiles, ADMET and physicochemical properties; characteristics of drug-delivery systems and virtual screening. EXPERT OPINION: Neural networks continue to grow in importance for drug discovery. Recent developments in deep learning suggests further improvements may be gained in the analysis of large chemical data sets. It's anticipated that neural networks will be more widely used in drug discovery in the future, and applied in non-traditional areas such as drug delivery systems, biologically compatible materials, and regenerative medicine.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1080/17460441.2016.1201262

Cites

113 of 113 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • DNN methods require substantially larger datasets to fully capitalize on their advantages.

    “DNN methods also require substantially larger datasets to fully capitalize on their advantages76”

    From QSAR without borders (2020) · cites this paper as [76]

  • New types of DNN have opened up new applications, allowing simpler molecular representations such as SMILES strings or chemical graphs to be used to generate useful toxicity models.

    “The development of new types of DNN76 has opened up new applications, allowing simpler molecular representations, such as SMILES strings or chemical graphs to be used to generate useful toxicity (and other property) models.”

    From QSAR without borders (2020) · cites this paper as [76]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Part of this paper’s reference list could not be split into single entries.

Flagged first, then by citations

5 of the 118 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Baskin, I. I., Winkler, D., & Tetko, I. V.
Affiliations
  • Lomonosov Moscow State University (RU)
  • Flinders University (AU)
  • Helmholtz Munich (DE)
Corresponding author
Tetko, Igor V.
Venue
Expert Opinion on Drug Discovery
Published
2016-07-04
Volume
11
Issue
8
Pages
785-795
ISSN
  • 1746-0441 (ISSN-L)
  • 1746-045X
OpenAlex
W2436108096
Cited by
235
References
118
Citations by year
2026: 12 · 2025: 18 · 2024: 25 · 2023: 24 · 2022: 41 · 2021: 26 · 2020: 26 · 2019: 21 · 2018: 27 · 2017: 8 · 2016: 7
FWCI
1.63
Type
journal article
Language
en
Open access
closed
Locations
  • Expert Opinion on Drug Discovery (publishedVersion)
  • PubMed (publishedVersion)
  • Site cant be reached (submittedVersion)
  • PuSH - Publication Server of Helmholtz Zentrum München (submittedVersion)
Topics
  • Physical Sciences › Computer Science › Computational Theory and Mathematics › Computational Drug Discovery Methods
  • Physical Sciences › Materials Science › Materials Chemistry › Machine Learning in Materials Science
  • Physical Sciences › Computer Science › Artificial Intelligence › Neural Networks and Applications
Keywords
artificial neural networks, drug discovery, BP neural network, self-organizing maps, deep learning, overfitting, regularization, ensemble learning, model interpretability, applicability domain, structure-activity relationship, toxicity prediction, ADMET prediction, physicochemical property prediction, drug delivery systems, virtual screening
MeSH terms
Pharmaceutical Preparations, Humans, Models, Biological, Structure-Activity Relationship, Drug Design, Drug Delivery Systems, Neural Networks, Computer, Computer-Aided Design, Drug Discovery

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review